These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 15737692)
1. Transforming growth factor-beta1 induces LMO7 while enhancing the invasiveness of rat ascites hepatoma cells. Nakamura H; Mukai M; Komatsu K; Tanaka-Okamoto M; Itoh Y; Ishizaki H; Tatsuta M; Inoue M; Miyoshi J Cancer Lett; 2005 Mar; 220(1):95-9. PubMed ID: 15737692 [TBL] [Abstract][Full Text] [Related]
2. RhoC is essential for TGF-beta1-induced invasive capacity of rat ascites hepatoma cells. Mukai M; Endo H; Iwasaki T; Tatsuta M; Togawa A; Nakamura H; Inoue M Biochem Biophys Res Commun; 2006 Jul; 346(1):74-82. PubMed ID: 16750170 [TBL] [Abstract][Full Text] [Related]
3. Direct activation of TGF-beta1 transcription by androgen and androgen receptor complex in Huh7 human hepatoma cells and its tumor in nude mice. Yoon G; Kim JY; Choi YK; Won YS; Lim IK J Cell Biochem; 2006 Feb; 97(2):393-411. PubMed ID: 16187311 [TBL] [Abstract][Full Text] [Related]
4. Lysyl oxidase like 4, a novel target gene of TGF-beta1 signaling, can negatively regulate TGF-beta1-induced cell motility in PLC/PRF/5 hepatoma cells. Kim DJ; Lee DC; Yang SJ; Lee JJ; Bae EM; Kim DM; Min SH; Kim SJ; Kang DC; Sang BC; Myung PK; Park KC; Yeom YI Biochem Biophys Res Commun; 2008 Sep; 373(4):521-7. PubMed ID: 18586005 [TBL] [Abstract][Full Text] [Related]
5. TGF-beta1-induced cell growth arrest and partial differentiation is related to the suppression of Id1 in human hepatoma cells. Damdinsuren B; Nagano H; Kondo M; Natsag J; Hanada H; Nakamura M; Wada H; Kato H; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Dono K; Monden M Oncol Rep; 2006 Feb; 15(2):401-8. PubMed ID: 16391861 [TBL] [Abstract][Full Text] [Related]
7. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells. Huang S; Zhang F; Miao L; Zhang H; Fan Z; Wang X; Ji G Oncol Rep; 2008 Nov; 20(5):1053-9. PubMed ID: 18949401 [TBL] [Abstract][Full Text] [Related]
8. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo. Moore LD; Isayeva T; Siegal GP; Ponnazhagan S Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771 [TBL] [Abstract][Full Text] [Related]
9. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes. Gotzmann J; Fischer AN; Zojer M; Mikula M; Proell V; Huber H; Jechlinger M; Waerner T; Weith A; Beug H; Mikulits W Oncogene; 2006 May; 25(22):3170-85. PubMed ID: 16607286 [TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor. Murakami M; Ikeda T; Saito T; Ogawa K; Nishino Y; Nakaya K; Funaba M Cell Signal; 2006 Feb; 18(2):256-65. PubMed ID: 15961275 [TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta-mediated tumor necrosis factor-related apoptosis-inducing ligand expression and apoptosis in hepatoma cells requires functional cooperation between Smad proteins and activator protein-1. Herzer K; Grosse-Wilde A; Krammer PH; Galle PR; Kanzler S Mol Cancer Res; 2008 Jul; 6(7):1169-77. PubMed ID: 18644981 [TBL] [Abstract][Full Text] [Related]
12. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis. Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894 [TBL] [Abstract][Full Text] [Related]
13. Expression of transforming growth factors in hepatocellular carcinoma and its relations with clinicopathological parameters and prognosis. Lu Y; Wu LQ; Li CS; Wang SG; Han B Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):174-8. PubMed ID: 18397854 [TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta1 and ethanol affect transcription and translation of genes and proteins for cell adhesion molecules in B104 neuroblastoma cells. Miller MW; Mooney SM; Middleton FA J Neurochem; 2006 May; 97(4):1182-90. PubMed ID: 16686695 [TBL] [Abstract][Full Text] [Related]
15. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. Zhang H; Ozaki I; Mizuta T; Hamajima H; Yasutake T; Eguchi Y; Ideguchi H; Yamamoto K; Matsuhashi S Oncogene; 2006 Oct; 25(45):6101-12. PubMed ID: 16682950 [TBL] [Abstract][Full Text] [Related]
16. Induction of transforming growth factor-beta1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation. Dhandapani KM; Khan MM; Wade FM; Wakade C; Mahesh VB; Brann DW J Neurosci Res; 2007 Apr; 85(5):1033-45. PubMed ID: 17335076 [TBL] [Abstract][Full Text] [Related]
17. The proteome of mouse mucosal mast cell homologues: the role of transforming growth factor beta1. Pemberton AD; Brown JK; Wright SH; Knight PA; Miller HR Proteomics; 2006 Jan; 6(2):623-31. PubMed ID: 16342142 [TBL] [Abstract][Full Text] [Related]
18. Autocrine production of TGF-beta confers resistance to apoptosis after an epithelial-mesenchymal transition process in hepatocytes: Role of EGF receptor ligands. Del Castillo G; Murillo MM; Alvarez-Barrientos A; Bertran E; Fernández M; Sánchez A; Fabregat I Exp Cell Res; 2006 Sep; 312(15):2860-71. PubMed ID: 16828470 [TBL] [Abstract][Full Text] [Related]
19. Local balance of transforming growth factor-beta1 secreted from cholangiocarcinoma cells and stromal-derived factor-1 secreted from stromal fibroblasts is a factor involved in invasion of cholangiocarcinoma. Ohira S; Itatsu K; Sasaki M; Harada K; Sato Y; Zen Y; Ishikawa A; Oda K; Nagasaka T; Nimura Y; Nakanuma Y Pathol Int; 2006 Jul; 56(7):381-9. PubMed ID: 16792547 [TBL] [Abstract][Full Text] [Related]
20. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD. Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]